Cargando…
Tuberculosis-immune reconstitution inflammatory syndrome
Tuberculosis-immune reconstitution inflammatory syndrome is an excessive immune response against Mycobacterium tuberculosis that may occur in either HIV-infected or uninfected patients, during or after completion of anti-TB therapy. In HIV-infected patients it occurs after initiation of antiretrovir...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850228/ https://www.ncbi.nlm.nih.gov/pubmed/31723680 http://dx.doi.org/10.1016/j.jctube.2016.03.002 |
_version_ | 1783469379032186880 |
---|---|
author | Lanzafame, Massimiliano Vento, Sandro |
author_facet | Lanzafame, Massimiliano Vento, Sandro |
author_sort | Lanzafame, Massimiliano |
collection | PubMed |
description | Tuberculosis-immune reconstitution inflammatory syndrome is an excessive immune response against Mycobacterium tuberculosis that may occur in either HIV-infected or uninfected patients, during or after completion of anti-TB therapy. In HIV-infected patients it occurs after initiation of antiretroviral therapy independently from an effective suppression of HIV viremia. There are two forms of IRIS: paradoxical or unmasking. Paradoxical IRIS is characterized by recurrent, new, or worsening symptoms of a treated case. Unmasking IRIS is an antiretroviral-associated inflammatory manifestation of a subclinical infection with a hastened presentation. The pathogenesis is incompletely understood and the epidemiology partially described. No specific tests can establish or rule out the diagnosis. Treatment is based on the use of anti-tuberculosis drugs sometime with adjunctive corticosteroids. Mortality is generally low. |
format | Online Article Text |
id | pubmed-6850228 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-68502282019-11-13 Tuberculosis-immune reconstitution inflammatory syndrome Lanzafame, Massimiliano Vento, Sandro J Clin Tuberc Other Mycobact Dis Article Tuberculosis-immune reconstitution inflammatory syndrome is an excessive immune response against Mycobacterium tuberculosis that may occur in either HIV-infected or uninfected patients, during or after completion of anti-TB therapy. In HIV-infected patients it occurs after initiation of antiretroviral therapy independently from an effective suppression of HIV viremia. There are two forms of IRIS: paradoxical or unmasking. Paradoxical IRIS is characterized by recurrent, new, or worsening symptoms of a treated case. Unmasking IRIS is an antiretroviral-associated inflammatory manifestation of a subclinical infection with a hastened presentation. The pathogenesis is incompletely understood and the epidemiology partially described. No specific tests can establish or rule out the diagnosis. Treatment is based on the use of anti-tuberculosis drugs sometime with adjunctive corticosteroids. Mortality is generally low. Elsevier 2016-03-11 /pmc/articles/PMC6850228/ /pubmed/31723680 http://dx.doi.org/10.1016/j.jctube.2016.03.002 Text en © 2016 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Lanzafame, Massimiliano Vento, Sandro Tuberculosis-immune reconstitution inflammatory syndrome |
title | Tuberculosis-immune reconstitution inflammatory syndrome |
title_full | Tuberculosis-immune reconstitution inflammatory syndrome |
title_fullStr | Tuberculosis-immune reconstitution inflammatory syndrome |
title_full_unstemmed | Tuberculosis-immune reconstitution inflammatory syndrome |
title_short | Tuberculosis-immune reconstitution inflammatory syndrome |
title_sort | tuberculosis-immune reconstitution inflammatory syndrome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850228/ https://www.ncbi.nlm.nih.gov/pubmed/31723680 http://dx.doi.org/10.1016/j.jctube.2016.03.002 |
work_keys_str_mv | AT lanzafamemassimiliano tuberculosisimmunereconstitutioninflammatorysyndrome AT ventosandro tuberculosisimmunereconstitutioninflammatorysyndrome |